N@N

EDWARDS LIFESCIENCES CORP (NYSE:EW), Up By 0.19% ($0.16) From $86.470 After BUYINS.NET Report Predicted Strength Before Earning

^{Published on 2011-06-10 05:21:06 - WOPRAI}
 

June 10, 2011 / M2 PRESSWIRE / BUYINS.NET, www.buyins.net , a provider of unique trading technologies, released a report on Wednesday, June 8th 2011 stating that EDWARDS LIFESCIENCES CORP (NYSE:EW) was expected to be Up Before its earnings release. Click here to view the BUYINS.NET report: http://www.buyins.net/releases/?sym=ew&id=171273

At the time this story was written, EDWARDS LIFESCIENCES CORP (NYSE:EW) is Up By 0.19% ($0.16) From $86.470 since the BUYINS.NET report was released.

The movement of stock prices in the days and weeks leading to and following earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php

EDWARDS LIFESCIENCES CORP (NYSE:EW) - Edwards Lifesciences Corporation provides products and technologies designed to treat advanced cardiovascular diseases. It offers products and technologies for heart valve therapy, critical care, cardiac surgery systems, and vascular diseases. The company provides tissue heart valves, such as pericardial and porcine valves, as well as repair products, including annuloplasty rings and systems used to replace or repair a patient's diseased or defective heart valve. It also offers hemodynamic monitoring equipment that is used to measure a patient's heart function in surgical and intensive care settings; and disposable pressure transducers. In addition, the company provides cardiac surgery systems products, including cannulae, intra-aortic filtration system, and other disposable products used during cardiopulmonary bypass procedures; and vascular products that comprise balloon-tipped and catheter-based embolectomy products, surgical clips, and clamps to treat endolumenal occlusive disease. Edwards Lifesciences Corporation distributes its products through a direct sales force and independent distributors worldwide. It has a collaboration agreement with DexCom, Inc. to develop products for monitoring blood glucose levels in patients hospitalized for various conditions. The company was founded in 1999 and is headquartered in Irvine, California. Edwards Lifesciences Corporation operates independently of Baxter International Inc., as of March 31, 2000.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market-maker surveillance system tracking market makers in all stocks to determine Price Friction and compliance with new "Fair Market-Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and all Threshold Security Lists daily for which stocks have naked short positions.

INVESTMENTS & TRADING

SqueezeTrigger -- 28 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts next move in stocks.

GATS -- tracks and quantifies known trading strategies.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. EDWARDS LIFESCIENCES CORP (NYSE:EW) has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net